Riluzole Tablet, Film Coated
Product Images NDC 69076-200

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 69076-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Manufacturer Info)

Label information for RILUZOLE 50 mg film-coated tablets, manufactured by Standard Chemical & Pharmaceutical Co., Ltd., located at NO. 154 Kaiyuan Road, Sinying District, Tainan City, Taiwan. The product is manufactured for Quinn Pharmaceuticals in Boca Raton, FL, with a toll-free contact number 844-477-8466. The label indicates the product is an oral prescription drug by Florida Pharmaceutical Products, LLC.*

FDA Label Image

Chemical-structure-riluzole (Spl Image 1 Structure)

Chemical structure of riluzole showing a benzothiazole ring with an amino group, a fluorophenoxy substituent, and a trifluoromethoxy group attached to the aromatic ring.*

FDA Label Image

Figure1 (Spl Image 2 Figure 1)

Kaplan-Meier survival curves comparing survival probability over months between RILUZOLE 50 mg twice daily (N=77) and placebo (N=78) groups.*

FDA Label Image

Figure2 (Spl Image 3 Figure 2)

A Kaplan-Meier survival curve graph comparing survival probability over time in months for RILUZOLE 50 mg taken twice daily (N=236) versus placebo (N=242). The y-axis shows survival probability from 0.1 to 1.0, and the x-axis shows time in months up to 21 months.*

FDA Label Image

Label (Spl Image 4 Label)

Riluzole Tablets, USP 50 mg film-coated tablets. The label states a package quantity of 60 tablets. Manufactured by Standard Chem. & Pharm. Co., Ltd., Taiwan, for Quinn Pharmaceuticals, Boca Raton, FL. The label includes dosage information, storage instructions, and a barcode.*

FDA Label Image

Table1 (Table1)

A data table comparing the percentage occurrence of various adverse events between patients taking Riluzole Tablets 50 mg twice daily and those taking a placebo. The table lists events such as asthenia, nausea, decreased lung function, hypertension, among others, with corresponding percentages for each group.*

FDA Label Image

Table2 (Table2)

A data table titled "Pharmacokinetic Parameters of Riluzole," detailing absorption, distribution, metabolism, and excretion characteristics. It includes information on oral bioavailability (approximately 60%), dose proportionality, food effect, plasma protein binding (96%), elimination half-life (12 hours), metabolism pathways (CYP1A2 and UGT-HP4), and primary elimination routes (feces and urine).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.